Form D · Pharmaceuticals

Lakewood-Amedex, Inc.

Sarasota, FL · CIK 0001614811

Offering snapshot reported Jan 22, 2021 · SEC filing

Reported sold
$24.1M
Offering amount: $40M
Investors reported
7
Form D · investor count
Minimum accepted
$250K
Reported outside-investor minimum
First sale
Jan 5, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 22, 2021Initial$24,075,000No comparison7SEC filing
Dec 24, 2019Initial$456,000No comparison3SEC filing
Sep 11, 2015Amendment$6,576,161$1,071,498vs Aug 18, 201475SEC filing
Aug 18, 2014Initial$5,504,663No comparison63SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-387098

Source: Form D, filed Jan 22, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Teddy Wallace Brown Director
Peter Ceccacci Executive
Peter Corr Director
Geoffrey Cox Director
Leonard De Roma Director
Paul Anthony Di Tullio Director, Executive
Richard Ford Hamm Executive
Edward Russell Mc Allister Executive
Stephen M Miley Director
Patrick Coleman O'connor Executive
Steven Parkinson Director, Executive
Steve Parkinson Director, Executive
Charles Wright Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3030 University Parkway
Sarasota, FL, 34243